CP
ZBH icon

Corbenic Partners’s Zimmer Biomet ZBH Stock Holding History

Corbenic Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-103
Closed -$11K – 220
2014
Q4 		$11K Hold
103
– – 0.01% 124
2014
Q3 		$10K Buy
+103
New +$10.1K 0.01% 83

Other funds holding ZBH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Corbenic Partners's ZBH Position: Q1 2015 in Review

Corbenic Partners sold out of Zimmer Biomet (ZBH) in Q1 2015, closing a stake of 103 shares — an estimated $11K sold.

Corbenic Partners first reported a position in ZBH in Q3 2014 and held it in 2 quarters. The position peaked at $11K in Q4 2014. 762 funds tracked by Wall St. Rank hold ZBH as of Q1 2015.

  • Corbenic Partners reported no remaining Zimmer Biomet position as of Q1 2015 after selling out during the quarter.
  • Corbenic Partners sold 103 Zimmer Biomet shares in Q1 2015, an estimated $11K.
  • Corbenic Partners first reported a position in Zimmer Biomet in Q3 2014 and held it in 2 quarters.
  • Corbenic Partners's Zimmer Biomet position peaked at $11K in Q4 2014.
  • 762 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2015.

Based on Corbenic Partners's 13F filing for Q1 2015, filed 16 Apr 2015.